Key Points Immuron’s Phase 2 study of once-daily Travelan has been published in Scientific Reports, a journal in the Nature portfolio. The study reported a…
October 13, 2026
October 13, 2026
BrainsWay Expands Insurance Coverage for Accelerated Deep TMS to Over 70 Million U.S. Lives
Key Points BrainsWay says favorable U.S. insurance policies for its SWIFT Accelerated Deep TMS protocol now cover more than 70 million lives. The expansion creates…
October 13, 2026
Oncolytics Expands Pelareorep Patent Portfolio, Targeting Protection Into the Late 2040s
Key Points Oncolytics has secured a new patent in several countries covering pelareorep’s use as a cancer immunotherapy, with a corresponding U.S. patent expected soon….
Key Points Hims & Hers has launched Hers in Australia, expanding its women’s health services across hair regrowth, menopause, perimenopause and weight management. The launch…
October 12, 2026
vTv Therapeutics Highlights Opportunity to Improve Type 1 Diabetes Care Alongside Automated Insulin Delivery
Key Points A survey presented by vTv Therapeutics found that low blood sugar remains a concern for many adults with type 1 diabetes who use…
Key Points A real-world analysis of 470 adults with irritable bowel syndrome with constipation, or IBS-C, found fewer gastrointestinal-related healthcare visits after patients started IBSRELA….
October 12, 2026
Palisade Bio Reports Early PALI-2108 Findings Supporting Phase 2 Studies in Ulcerative Colitis and Crohn’s Disease
Key Points Palisade Bio presented five research posters on its experimental oral treatment, PALI-2108, at ACG 2026. Small, early-stage studies showed improvements in symptoms, intestinal…
October 13 is Metastatic Breast Cancer Awareness Day, which spotlights the stage of breast cancer that still has no cure and the emerging companies working…
Key Points Humacyte’s interim Phase 3 V012 results were accepted for a late-breaking oral presentation at ASN Kidney Week 2026. The randomized trial compares its…
AstraZeneca attributes its Phase 3 HICKORY miss in hypophosphatasia to trial design, as Mereo seeks a path forward with the FDA and Mirum wins approval…
World Mental Health Day 2026: Why Lived Experience Now Moves Markets This Saturday, October 10, marks World Mental Health Day. The World Federation for Mental…
Key Points Sagimet is presenting long-term results for its experimental acne pill, denifanstat, at a dermatology conference in Las Vegas. A study in China reported…